Fig. 5
From: Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathway

miR-338-3p attenuated glioma progression by inhibiting THBS1 to inactivate the PI3K/Akt pathway
From: Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathway
miR-338-3p attenuated glioma progression by inhibiting THBS1 to inactivate the PI3K/Akt pathway